Filing Flows › Comparisons › RYTM vs AUPH
Rhythm Pharmaceuticals vs Aurinia Pharmaceuticals: RYTM and AUPH compared
Rhythm Pharmaceuticals is the larger company: $92.1M of revenue in its latest quarter (Q3 2026) against $83.7M for Aurinia Pharmaceuticals (Q3 2026). Rhythm Pharmaceuticals is growing faster (+80% against +14% a year earlier). Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against -42.6%.
Where the money goes: RYTM and AUPH
Rhythm Pharmaceuticals (RYTM) · Q3 2026
Rhythm Pharmaceuticals, Q3 2026: revenue $92.1M (+80% year over year), operating margin -42.6%, net loss $41.4M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
Aurinia Pharmaceuticals (AUPH) · Q3 2026
Aurinia Pharmaceuticals, Q3 2026: revenue $83.7M (+14% year over year), operating margin 42.3%, net earnings $31.7M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
| Rhythm Pharmaceuticals (RYTM) | Aurinia Pharmaceuticals (AUPH) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $92.1M | $83.7M |
| Revenue growth, Y/Y | +80% | +14% |
| Operating margin | -42.6% | 42.3% |
| Net earnings | −$41.4M | $31.7M |
| Net margin | -44.9% | 37.9% |
| Operating cash flow | −$3.1M | $46.4M |
| Market value | — | $2.2B |
| P/E | — | 7.2× |
| Analysts’ mean target | — | $18.29 |
Where the revenue comes from
Aurinia Pharmaceuticals
- Net product sales: $79.4M (95%)
- License, collaboration and royalty revenue: $4.3M (5%)
Questions
Which is bigger, Rhythm Pharmaceuticals or Aurinia Pharmaceuticals?
Rhythm Pharmaceuticals is the larger company: $92.1M of revenue in its latest quarter (Q3 2026) against $83.7M for Aurinia Pharmaceuticals (Q3 2026).
Is Rhythm Pharmaceuticals or Aurinia Pharmaceuticals growing faster?
Rhythm Pharmaceuticals is growing faster (+80% against +14% a year earlier).
Which is more profitable, Rhythm Pharmaceuticals or Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against -42.6%.
More: Rhythm Pharmaceuticals earnings · how Rhythm Pharmaceuticals makes money · Aurinia Pharmaceuticals earnings · how Aurinia Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.